ADC Therapeutics Non-GAAP EPS of -$0.22, revenue of $23.03M beats by $5.32M

1 month ago 4

Earnings News

ADC Therapeutics press release (NYSE:ADCT): Q1 Non-GAAP EPS of -$0.22.
Revenue of $23.03M (+27.6% Y/Y) beats by $5.32M.
As of March 31, 2025, cash and cash equivalents were $194.7 million, compared to $250.9 million as of December 31, 2024, a change primarily driven by the timing of

Recommended For You

More Trending News

Read Entire Article